These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25603042)

  • 1. FDA regulation of adult stem cell therapies as used in sports medicine.
    Chirba MA; Sweetapple B; Hannon CP; Anderson JA
    J Knee Surg; 2015 Feb; 28(1):55-62. PubMed ID: 25603042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine.
    Beitzel K; Allen D; Apostolakos J; Russell RP; McCarthy MB; Gallo GJ; Cote MP; Mazzocca AD
    J Knee Surg; 2015 Feb; 28(1):29-34. PubMed ID: 25268794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Food and Drug Administration, regenerative sciences, and the regulation of autologous stem cell therapies.
    von Tigerstrom B
    Food Drug Law J; 2011; 66(4):479-506, i. PubMed ID: 24505826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA's claims over stem cells upheld.
    Cyranoski D
    Nature; 2012 Aug; 488(7409):14. PubMed ID: 22859178
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA challenges stem-cell clinic.
    Cyranoski D
    Nature; 2010 Aug; 466(7309):909. PubMed ID: 20725009
    [No Abstract]   [Full Text] [Related]  

  • 6. From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
    Knoepfler PS
    Adv Drug Deliv Rev; 2015 Mar; 82-83():192-6. PubMed ID: 25489841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Texas prepares to fight for stem cells.
    Cyranoski D
    Nature; 2011 Sep; 477(7365):377-8. PubMed ID: 22049545
    [No Abstract]   [Full Text] [Related]  

  • 8. 2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development.
    Couture LA; Carpenter MK
    Stem Cells Transl Med; 2015 Oct; 4(10):1097-100. PubMed ID: 26285658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA regulation of stem-cell-based therapies.
    Halme DG; Kessler DA
    N Engl J Med; 2006 Oct; 355(16):1730-5. PubMed ID: 17050899
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
    Harapanhalli RS
    Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating autologous adult stem cells: the FDA steps up.
    Lysaght T; Campbell AV
    Cell Stem Cell; 2011 Nov; 9(5):393-6. PubMed ID: 22056136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA scrutinizes human stem cell therapies.
    Fox JL
    Nat Biotechnol; 2008 Jun; 26(6):598-9. PubMed ID: 18536668
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem cells. Texas Medical Board approves rules for controversial treatment.
    Kaiser J
    Science; 2012 Apr; 336(6079):284. PubMed ID: 22517830
    [No Abstract]   [Full Text] [Related]  

  • 15. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem-cell-derived products: an FDA update.
    Moos M
    Trends Pharmacol Sci; 2008 Dec; 29(12):591-3. PubMed ID: 18937983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA should stand firm on stem-cell treatments.
    Nature; 2016 Jul; 535(7610):7-8. PubMed ID: 27383946
    [No Abstract]   [Full Text] [Related]  

  • 19. Amendments to general regulations of the Food and Drug Administration. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Nov; 75(229):73951-5. PubMed ID: 21121182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further amendments to general regulations of the Food and Drug Administration to incorporate tobacco products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(22):5171-6. PubMed ID: 22359802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.